Axon Enterprise, Inc. (NASDAQ:AXON) Receives $604.67 Average PT from Brokerages

Axon Enterprise, Inc. (NASDAQ:AXON - Get Free Report) has been given an average recommendation of "Moderate Buy" by the fourteen research firms that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and eleven have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $604.67.

A number of research analysts have weighed in on AXON shares. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC reaffirmed a "buy" rating and issued a $600.00 price target on shares of Axon Enterprise in a report on Wednesday, February 26th. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective on the stock. Craig Hallum downgraded Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Robert W. Baird lifted their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research note on Friday, December 6th.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jeffrey C. Kunins sold 1,035 shares of the stock in a transaction that occurred on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the completion of the transaction, the insider now owns 124,243 shares of the company's stock, valued at $77,586,026.21. The trade was a 0.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,792 shares of company stock valued at $1,087,843. Insiders own 5.70% of the company's stock.

Remove Ads

Institutional Trading of Axon Enterprise

A number of hedge funds and other institutional investors have recently modified their holdings of AXON. Vanguard Group Inc. raised its stake in shares of Axon Enterprise by 3.4% in the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock valued at $5,019,886,000 after acquiring an additional 275,959 shares during the period. Geode Capital Management LLC raised its position in Axon Enterprise by 3.7% in the fourth quarter. Geode Capital Management LLC now owns 1,847,925 shares of the biotechnology company's stock valued at $1,095,542,000 after purchasing an additional 65,097 shares during the period. Capital World Investors boosted its position in shares of Axon Enterprise by 86.4% during the fourth quarter. Capital World Investors now owns 1,815,765 shares of the biotechnology company's stock worth $1,079,145,000 after buying an additional 841,772 shares during the period. Westfield Capital Management Co. LP raised its holdings in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after buying an additional 127,769 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock worth $659,128,000 after acquiring an additional 812,337 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Axon Enterprise Stock Performance

Shares of NASDAQ AXON traded up $21.66 during trading on Friday, reaching $561.65. 295,849 shares of the company traded hands, compared to its average volume of 846,262. Axon Enterprise has a 12-month low of $273.52 and a 12-month high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a market cap of $43.04 billion, a P/E ratio of 145.13, a PEG ratio of 5.17 and a beta of 1.12. The firm's fifty day simple moving average is $592.66 and its 200 day simple moving average is $539.27.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.